Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen Inc.
With
MacuSight, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with diabetes mellitus
Macular edema secondary to diabetic retinopathy
Visual acuity of 20/40 to 20/200 in study eye
You may not be if
Any other ocular disease that could compromise vision in the study eye
Any of the following treatments to the study eye within 90 days prior to study start: intravitreal injections; posterior subtenons steroids; focal/grid macular photocoagulation; intraocular surgery
Capsulotomy of the study eye within 30 days prior to study start
Clareo Health | Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
